2 results
Approved WMOCompleted
To demonstrate non-inferiority of a T2T strategy in which conventional synthetic disease modifying drugs (csDMARDs) refractory RApatients are initially treated with tsDMARD baricitinib versus the comparable T2T strategy in which patients areā¦
Approved WMORecruiting
The proposed pilot study will examine whether radiation-based CTA could be replaced with MRI in three phases of AAA management.